APA (7th ed.) Citation

G, Z., LM, B., C, B., S, R., DL, W., S, S., . . . L, A. (2026). Clinical development of tacrolimus-resistant regulatory T cells to enable simultaneous immunosuppression and immune regulation. Molecular therapy. Advances, 34(2), 201735. https://doi.org/10.1016/j.omta.2026.201735

Chicago Style (17th ed.) Citation

G, Zarrinrad, et al. "Clinical Development of Tacrolimus-resistant Regulatory T Cells to Enable Simultaneous Immunosuppression and Immune Regulation." Molecular Therapy. Advances 34, no. 2 (2026): 201735. https://doi.org/10.1016/j.omta.2026.201735.

MLA (9th ed.) Citation

G, Zarrinrad, et al. "Clinical Development of Tacrolimus-resistant Regulatory T Cells to Enable Simultaneous Immunosuppression and Immune Regulation." Molecular Therapy. Advances, vol. 34, no. 2, 2026, p. 201735, https://doi.org/10.1016/j.omta.2026.201735.